Literature DB >> 17401206

Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease.

Roxana M Coman1, Arthur Robbins, Maureen M Goodenow, Robert McKenna, Ben M Dunn.   

Abstract

Crystals of the human immunodeficiency virus 1 (HIV-1) subtype C protease (PR) complexed with the clinically used inhibitors indinavir (IDV) and nelfinavir (NFV) have been grown in the monoclinic space group P2(1), with mean unit-cell parameters a = 46.7 (+/-0.1), b = 59.8 (+/-0.3), c = 87.0 (+/-0.4) A, beta = 95.2 (+/-0.5) degrees. The crystals of both complexes have been shown to diffract X-rays to 2.3 A resolution. The diffraction data for the subtype C PR complexes with IDV and NFV were subsequently processed and reduced, with overall R(sym) values of 8.4 and 11.4%, respectively. Based on the unit-cell volumes, molecular-replacement results and packing considerations, there are two protease homodimers per crystallographic asymmetric unit in each of the complexes. The data were initially phased using a model based on the crystal structure of HIV-1 subtype B PR; the structures have been determined and further refinement and analysis are in progress. These structures and subsequent studies with other inhibitors will greatly aid in correlating the amino-acid variation between the different HIV PRs and understanding their differential sensitivity and resistance to current drug therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401206      PMCID: PMC2330223          DOI: 10.1107/S174430910701161X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  37 in total

1.  Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy.

Authors:  L Romano; G Venturi; R Ferruzzi; M L Riccio; P Corsi; F Leoncini; A Vinattieri; L Incandela; P E Valensin; M Zazzi
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

2.  Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site.

Authors:  Bhuvaneshwari Mahalingam; Yuan-Fang Wang; Peter I Boross; Jozsef Tozser; John M Louis; Robert W Harrison; Irene T Weber
Journal:  Eur J Biochem       Date:  2004-04

3.  Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia.

Authors:  Paulo R Batista; Alan Wilter; Elza H A B Durham; Pedro G Pascutti
Journal:  Cell Biochem Biophys       Date:  2006       Impact factor: 2.194

4.  A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil.

Authors:  Marcelo A Soares; Tulio De Oliveira; Rodrigo M Brindeiro; Ricardo S Diaz; Ester C Sabino; Luís Brigido; Ivone L Pires; Mariza G Morgado; Maria C Dantas; Draurio Barreira; Paulo R Teixeira; Sharon Cassol; Amilcar Tanuri
Journal:  AIDS       Date:  2003-01-03       Impact factor: 4.177

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

Authors:  Grace P McCormack; Judith R Glynn; Amelia C Crampin; Felix Sibande; Dominic Mulawa; Lyn Bliss; Philip Broadbent; Katia Abarca; Jorg M Pönnighaus; Paul E M Fine; Jonathan P Clewley
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.

Authors:  Maureen M Goodenow; Gregory Bloom; Stephanie L Rose; Steven M Pomeroy; Patricia O O'Brien; Elena E Perez; John W Sleasman; Ben M Dunn
Journal:  Virology       Date:  2002-01-05       Impact factor: 3.616

8.  Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000.

Authors:  Saladin Osmanov; Claire Pattou; Neff Walker; Bernhard Schwardländer; Jose Esparza
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

9.  Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.

Authors:  Zehava Grossman; Ellen E Paxinos; Diana Averbuch; Shlomo Maayan; Neil T Parkin; Dan Engelhard; Margalit Lorber; Valery Istomin; Yael Shaked; Ella Mendelson; Daniela Ram; Chris J Petropoulos; Jonathan M Schapiro
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

Authors:  M Miller; J Schneider; B K Sathyanarayana; M V Toth; G R Marshall; L Clawson; L Selk; S B Kent; A Wlodawer
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

View more
  3 in total

1.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

2.  Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Authors:  Arthur H Robbins; Roxana M Coman; Edith Bracho-Sanchez; Marty A Fernandez; C Taylor Gilliland; Mi Li; Mavis Agbandje-McKenna; Alexander Wlodawer; Ben M Dunn; Robert McKenna
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-02-12

3.  Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.

Authors:  Rajintha M Bandaranayake; Moses Prabu-Jeyabalan; Junko Kakizawa; Wataru Sugiura; Celia A Schiffer
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.